Figure 1 (IMAGE)

Tohoku University

Figure 1

Caption

By specifically targeting HER2-positive cells, the monoclonal antibody inhibits the growth and division of cancerous cells while minimizing damage to adjacent healthy tissue. 

Credit

Yukinari Kato et al.

Usage Restrictions

Reporters may use freely these materials in news coverage with appropriate credit information.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.